INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹142 Cr | ₹155 Cr | ₹93 Cr | ₹24 Cr | ₹-2.90 Cr |
What is the latest Consolidated Net Profit of INDOCO REMEDIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹142 Cr |
Mar2023 | ₹155 Cr |
Mar2022 | ₹93 Cr |
Mar2021 | ₹24 Cr |
Mar2020 | ₹-2.90 Cr |
How is Consolidated Net Profit of INDOCO REMEDIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹142 Cr | -8.11 | |
Mar2023 | ₹155 Cr | 66.37 | |
Mar2022 | ₹93 Cr | 285.81 | |
Mar2021 | ₹24 Cr | Positive | |
Mar2020 | ₹-2.90 Cr | - |
Compare Consolidated Net Profit of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹2,983.1 Cr | 1.3% | 15.7% | -0.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | 1.3% |
15.7% |
-0.5% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses